NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
1.150
+0.030 (2.68%)
At close: Feb 21, 2025, 4:00 PM
1.160
+0.010 (0.87%)
After-hours: Feb 21, 2025, 4:00 PM EST
NMTC Revenue
NeuroOne Medical Technologies had revenue of $3.27M in the quarter ending December 31, 2024, with 234.90% growth. This brings the company's revenue in the last twelve months to $5.75M, up 104.21% year-over-year. In the fiscal year ending September 30, 2024, NeuroOne Medical Technologies had annual revenue of $3.45M with 1.33% growth.
Revenue (ttm)
$5.75M
Revenue Growth
+104.21%
P/S Ratio
5.70
Revenue / Employee
$338,207
Employees
17
Market Cap
35.49M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 3.45M | 45.37K | 1.33% |
Sep 30, 2023 | 3.41M | 1.29M | 60.73% |
Sep 30, 2022 | 2.12M | 1.88M | 772.60% |
Sep 30, 2021 | 242.96K | -1.68M | -87.39% |
Sep 30, 2020 | 1.93M | - | - |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
NMTC News
- 10 days ago - NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 16 days ago - NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time - GlobeNewsWire
- 17 days ago - NeuroOne® Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 6 weeks ago - NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million - GlobeNewsWire
- 6 weeks ago - Stock Picks From Seeking Alpha's December 2024 New Analysts - Seeking Alpha
- 7 weeks ago - NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST - GlobeNewsWire
- 2 months ago - NeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call Transcript - Seeking Alpha